An act relating to increasing the transparency of prescription drug costs and spending

This bill aims to increase transparency around prescription drug costs. It would prevent pharmacy benefit managers from charging patients more than the national average cost plus a dispensing fee. Pharmacies would need to inform customers they can ask for price options, and hospitals in the 340B drug program would have to report their participation annually. Health insurers would also have to tell people how much their plan spent on their prescriptions, and 340B program participants would need to inform patients if their drugs were bought through the program.

No official summary on file for this bill · generated by Gemini 2.5 Flash from its full text